Received by email:

File: Lotus Ventures News Release September 11 2018.docx

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES


/

Suite 1010 - 1030 West Georgia Street, Vancouver, British Columbia V6E 2Y3 

Canadian Securities Exchange:  Symbol J 

Vancouver, British Columbia - September 11, 2018


LOTUS ANNOUNCES PRIVATE PLACEMENT 

The Offering will consist of up to 8,000,000 units ("Units") at a purchase price of $0.25 per Unit, for aggregate gros
--->s proceeds of up to $2,000,000. Each Unit will consist of one common share in the capital of the Company ("Common Shar
--->e") and one common share purchase warrant ("Warrant"). Each Warrant will entitle the holder to purchase one Common Sha
--->re for a period of five years from the date of issuance, at a purchase price of $0.30. The company may pay a 5% cash f
--->inders fee. The proceeds from the Offering will be used for working capital and general corporate purposes.

ON BEHALF OF THE BOARD
Lotus Ventures Inc.
"Dale McClanaghan" Dale McClanaghan, President and CEO

For further information: Dale McClanaghan: dalemcclanaghan@gmail.com (604) 644-9844

Forward-Looking Information 
This news release contains certain "forward-looking information" within the meaning of applicable Canadian securities 
--->law. Forward-looking information is frequently characterized by words such as "plan", "continue", "expect", "project",
---> "intend", "believe", "anticipate", "estimate", "may", "will", "potential", "proposed" and other similar words, or inf
--->ormation that certain events or conditions "may" or "will" occur. This information is only a prediction. Various assum
--->ptions were used in drawing the conclusions or making the projections contained in the forward-looking information thr
--->oughout this news release. Forward-looking information includes, but is not limited to: receipt of regulatory approval
--->s of the Offering, inability to complete the Offering on the proposed terms or at all, delays in obtaining or inabilit
--->y to obtain required government or other regulatory approvals, including licenses to cultivate cannabis, regulatory or
---> political change, competition and other risks affecting the Company in particular and the medical cannabis industry g
--->enerally. Forward-looking information is based on the opinions and estimates of management at the date the information
---> is made, and is subject to a variety of risks and uncertainties and other factors that could cause actual events or r
--->esults to differ materially from those projected in the forward-looking information. The Company is under no obligatio
--->n, and expressly disclaims any intention or obligation, to update or revise any forward-looking information, whether a
--->s a result of new information, future events or otherwise, except as expressly required by applicable law.

The Canadian Securities Exchange does not accept responsibility for the adequacy or accuracy of this release.


File: Lotus Ventures News Release September 11 2018.docx

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES


/

Suite 1010 - 1030 West Georgia Street, Vancouver, British Columbia V6E 2Y3 

Canadian Securities Exchange:  Symbol J 

Vancouver, British Columbia - September 11, 2018


LOTUS ANNOUNCES PRIVATE PLACEMENT 

The Offering will consist of up to 8,000,000 units ("Units") at a purchase price of $0.25 per Unit, for aggregate gros
--->s proceeds of up to $2,000,000. Each Unit will consist of one common share in the capital of the Company ("Common Shar
--->e") and one common share purchase warrant ("Warrant"). Each Warrant will entitle the holder to purchase one Common Sha
--->re for a period of five years from the date of issuance, at a purchase price of $0.30. The company may pay a 5% cash f
--->inders fee. The proceeds from the Offering will be used for working capital and general corporate purposes.

ON BEHALF OF THE BOARD
Lotus Ventures Inc.
"Dale McClanaghan" Dale McClanaghan, President and CEO

For further information: Dale McClanaghan: dalemcclanaghan@gmail.com (604) 644-9844

Forward-Looking Information 
This news release contains certain "forward-looking information" within the meaning of applicable Canadian securities 
--->law. Forward-looking information is frequently characterized by words such as "plan", "continue", "expect", "project",
---> "intend", "believe", "anticipate", "estimate", "may", "will", "potential", "proposed" and other similar words, or inf
--->ormation that certain events or conditions "may" or "will" occur. This information is only a prediction. Various assum
--->ptions were used in drawing the conclusions or making the projections contained in the forward-looking information thr
--->oughout this news release. Forward-looking information includes, but is not limited to: receipt of regulatory approval
--->s of the Offering, inability to complete the Offering on the proposed terms or at all, delays in obtaining or inabilit
--->y to obtain required government or other regulatory approvals, including licenses to cultivate cannabis, regulatory or
---> political change, competition and other risks affecting the Company in particular and the medical cannabis industry g
--->enerally. Forward-looking information is based on the opinions and estimates of management at the date the information
---> is made, and is subject to a variety of risks and uncertainties and other factors that could cause actual events or r
--->esults to differ materially from those projected in the forward-looking information. The Company is under no obligatio
--->n, and expressly disclaims any intention or obligation, to update or revise any forward-looking information, whether a
--->s a result of new information, future events or otherwise, except as expressly required by applicable law.

The Canadian Securities Exchange does not accept responsibility for the adequacy or accuracy of this release.